Bipolar patient. Chapter I - Recognizing bipolarity: Its identity, frequency and risks;Chapitre I - Reconnaître la bipolarité: Son identité, sa fréquence et ses risques

Annales Medico-Psychologiques

Volumn 162, Issue 2, 2004, Pages 155-159

  Hantouche, E G ^a   Akiskal, H S ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; LITHIUM SALT; NEUROLEPTIC AGENT; SEDATIVE AGENT; TRANQUILIZER;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MANIA; MORBIDITY; PATIENT COMPLIANCE; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 1642292561     PISSN: 00034487     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amp.2004.01.001     Document Type: Article

References (7)

1. Akiskal HS, Bourgeois ML, Angst J, et al. Re-evaluating the prevalence and the diagnostic compositions within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000;59(suppl 1):5-30.
2. Allilaire JF, Hantouche EG, Sechter D, et al. Fréquence et aspects cliniques du Trouble BP-II : EPIDEP. Encéphale 2001;27:149-58.
3. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998;50:143-52.
4. Hantouche EG. Le spectre des troubles bipolaires. «dossier : Les Troubles Bipolaires» Santé Mentale, 56. mars 2001. p. 22-8.
5. Hantouche EG, Kochman F, Akiskal HS. Évaluation des tempéraments affectifs : version complète d'auto- évaluation. Encéphale 2001;27(sp, 3):24-30.
6. Hirshfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003;64:53-9.
7. Perdrizet-Chevalier C, Hantouche EG. Évolution des aspects cliniques et thérapeutiques des troubles bipolaires. Ann Méd Psychol 2001;159:654-60.